Incidentalome_PREGEN_DRAFT

Gene: TREM2

Amber List (moderate evidence)

TREM2 (triggering receptor expressed on myeloid cells 2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000095970
EnsemblGeneIds (GRCh37): ENSG00000095970
OMIM: 605086, ClinGen, DECIPHER
TREM2 is in 9 panels

1 review

Tony Roscioli (New South Wales Health Pathology)

Green List (high evidence)

Comment on list classification: Neurological symptoms appear not to present in childhood - needs review for a final decision
Created: 20 Jan 2021, 4:14 p.m.
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
onset after childhood for neurological and other symptoms
Created: 20 Jan 2021, 3:42 p.m.

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
20 Jan 2021, Gel status: 2

Entity classified by Genomics England curator

Tony Roscioli (New South Wales Health Pathology)

Gene: trem2 has been classified as Amber List (Moderate Evidence).

9 Nov 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: TREM2 was added gene: TREM2 was added to Incidentalome_NSW. Sources: Expert Review Green,NSW Health Pathology Mode of inheritance for gene: TREM2 was set to Unknown